Karlie Kay Novian, FNP-C | |
1901 Medi Park Dr Ste 2001, Amarillo, TX 79106-2108 | |
(806) 468-4350 | |
(806) 468-4351 |
Full Name | Karlie Kay Novian |
---|---|
Gender | Female |
Speciality | Nurse Practitioner - Family |
Location | 1901 Medi Park Dr Ste 2001, Amarillo, Texas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285221721 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 1018803 (Texas) | Secondary |
208000000X | Pediatrics | 1018803 (Texas) | Secondary |
363LF0000X | Nurse Practitioner - Family | 1018803 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Karlie Kay Novian, FNP-C 1901 Medi Park Dr Ste 2001, Amarillo, TX 79106-2108 Ph: (806) 468-4350 | Karlie Kay Novian, FNP-C 1901 Medi Park Dr Ste 2001, Amarillo, TX 79106-2108 Ph: (806) 468-4350 |
News Archive
Roche announced today that the US Food and Drug Administration has provided 510(k) clearance for the cobas Cdiff Test to detect Clostridium difficile (C. difficile) in stool specimens.
Gen-Probe Incorporated announced today that the Company has submitted a 510(k) application to the US Food and Drug Administration (FDA) for its APTIMA® Trichomonas vaginalis assay on the fully automated TIGRIS® system.
Ecology Coatings, Inc., a leader in the discovery and development of nanotechnology-enabled, ultraviolet-curable advanced coatings, today announced that it has signed a collaboration agreement with a major tobacco company for the application of its technology for producing "fire standard compliant" (FSC) cigarettes.
PointCare Technologies, pioneer inventor of a portable diagnostic system that enables effective HIV/AIDS monitoring for millions of people in remote areas of developing countries, has donated 4,000 (a month's supply) of its rapid PointCare NOW tests to Haitian clinics to ensure the resumption of critical care to HIV/AIDS patients.
Researchers at Lund University in Sweden, in collaboration with colleagues in Dresden, Germany, have developed a way of combining a bone substitute and drugs to regenerate bone and heal severe fractures in the thigh or shin bone.
› Verified 4 days ago